Fabbri et al. (2013) noted that NOTCH1 mutations were infrequent in de novo DLBCL but were noted in 8.3% of cases of CLL at diagnosis and at much higher rates in refractory CLL (20.8%) and RS (31%). This evidence concerns the gene NOTCH1 and diffuse large B-cell lymphoma.